Abstract
Abstract Despite improved survival, renal transplant recipients remain at a high risk of increased mortality and mortality from cardiovascular disease. Both traditional cardiovascular disease (CVD) risk factors and those unique to this population add to the burden of disease, making their CVD risk 50 times that of the general population. This article discusses our present understanding of cardiovascular disease, the risk factors, including dyslipidemia, hypertension, allograft rejection and dysfunction, anemia, proteinuria and new onset diabetes after transplantation (NODAT), as well as prevention and management of these risk factors. Cardiovascular interventions as well as future considerations are also briefly discussed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
